The malignant clone in Waldenstrom's macroglobulinemia

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 132-135

  Kriangkum, Jitra ^a,b   Taylor, Brian J ^a,b   Mant, Michael J ^a,b   Treon, Steven P ^a,b   Belch, Andrew R ^a,b   Pilarski, Linda M ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; IMMUNOGLOBULIN M; SYNDECAN 1;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; B LYMPHOCYTE; BONE MARROW; CLONE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LONGITUDINAL STUDY; MORPHOLOGICAL TRAIT; PHENOTYPE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REVIEW; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0242586139     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50061     Document Type: Review

References (16)

1. Dimopoulos M, Galani E, Matsouka C: Waldenström's macroglobulenimia. Hematol Oncol Clin North Am 13:1351-1366, 1999
2. Duong Van Huyen J-P, Molina T, Delmer A, et al: Splenic marginal zone mymphoma with or without plasmacytic differentiation. Am J Surg Pathol 24:1581-1592, 2000
3. Morel P, Monconduit M, Jacomy D, et al: Prognostic factors in Waldenström's macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852-858, 2000
4. Diebold, J, Molina, T, Tisser, F, et al: Waldenström's macrogobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphoma. Leukemia 13:1637-1638, 1999
5. Owen RG, Johnson SA, Morgan GJ: Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment. Hematol Oncol 18:41-49, 2000
6. + B lineage in Waldenstrom's macroglobulinemia. Am J Hematol 37:20-30, 1991
7. Wagner SD, Martinelli V, Luzzato L: Similar patterns of Vk usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenström's macroglobulinemia ad myeloma. Blood 83:3647-3653, 1994
8. Aoki H, Takishita M, Kosaka M, et al: Frequent somatic mutations in D and/or Jh segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Ritchter's syndrome but not in commmon CLL. Blood 85:1913-1919, 1995
9. Ciric B, VenKeulen V, Rodriguez M, et al: Clonal evolution in Waldenström's macroglobulinemia highlights the functional role of B cell receptor. Blood 97:321-323, 2001
10. Jensen GS, Poppema S, Mant MJ, et al: Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1:229-236, 1989
11. Pilarski LM, Andrews EJ, Serra HM, et al: Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstroms macroglobulinemia, multiple myeloma and I IgM monoclonal gammopathy of undetermined significance. Am J Hematol 30:53-60, 1989
12. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297-322, 1992
13. Pilarski LM, Mant MJ, Ruether BA: Review: Analysis of immunodeficiency in multiple myeloma: Observations and hypothesis. J Clin Lab Anal 1:214-288, 1987
14. Sahota SS, Forconi F, Ottensmeier CH, et al: Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 100:1505-1507, 2002
15. Sahota SS, Garand R, Mahroof R, et al: V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Blood 94:1070-1076, 1999
16. Sahota SS, Garand R, Bataille R, et al: VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood 91:238-243, 1998